Award
Delivery Order #SPE2DP26F3026
Delivery Order for Docusate Sodium from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.72
Ceiling
$8.72
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Mar 10, 2026
Identifier
SPE2DP26F3026
NAICS
424210
This award represents a delivery order contract executed under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a well-established pharmaceutical distributor. The order focuses on procuring docusate sodium capsules, a medication used to treat constipation, supporting the agency's ongoing healthcare and pharmaceutical supply initiatives. The scope involves the timely delivery of this specific pharmaceutical product to be shipped to Park Ridge, Illinois, within a concise and defined performance period in early 2026. This contract order complements a larger definitive pharmaceutical supply contract awarded to DMS Pharmaceutical Group, which ensures a comprehensive portfolio of critical medications are available to meet federal health agency requirements. Issued under a competitive framework as part of the overarching IDV, the delivery order underscores the agency's strategic approach to maintaining an uninterrupted supply of essential medicines. The short, focused timeline reflects the need for swift fulfillment of medical supply needs within the broader multi-year contract structure.
Description
8511938721!DOCUSATE SODIUM CAP